AP2000001907A0 - Crystalline form of paroxetine. - Google Patents
Crystalline form of paroxetine.Info
- Publication number
- AP2000001907A0 AP2000001907A0 APAP/P/2000/001907A AP2000001907A AP2000001907A0 AP 2000001907 A0 AP2000001907 A0 AP 2000001907A0 AP 2000001907 A AP2000001907 A AP 2000001907A AP 2000001907 A0 AP2000001907 A0 AP 2000001907A0
- Authority
- AP
- ARIPO
- Prior art keywords
- paroxetine
- crystalline form
- free
- therapy
- pure
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002296 paroxetine Drugs 0.000 title abstract 2
- 239000012458 free base Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2000001907A0 true AP2000001907A0 (en) | 2000-09-30 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2000/001907A AP2000001907A0 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (xx) |
| JP (1) | JP2002506865A (xx) |
| KR (1) | KR20010041947A (xx) |
| CN (1) | CN1300286A (xx) |
| AP (1) | AP2000001907A0 (xx) |
| AU (1) | AU2847199A (xx) |
| BG (1) | BG104839A (xx) |
| BR (1) | BR9908825A (xx) |
| CA (1) | CA2323896A1 (xx) |
| EA (1) | EA200000946A1 (xx) |
| HU (1) | HUP0101215A3 (xx) |
| ID (1) | ID27596A (xx) |
| IL (1) | IL138390A0 (xx) |
| NO (1) | NO20004583L (xx) |
| PL (1) | PL342931A1 (xx) |
| SK (1) | SK13622000A3 (xx) |
| TR (1) | TR200002675T2 (xx) |
| WO (1) | WO1999047519A1 (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
-
1999
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1064282A1 (en) | 2001-01-03 |
| BG104839A (en) | 2001-09-28 |
| HUP0101215A2 (hu) | 2002-04-29 |
| KR20010041947A (ko) | 2001-05-25 |
| TR200002675T2 (tr) | 2000-12-21 |
| EA200000946A1 (ru) | 2001-02-26 |
| NO20004583D0 (no) | 2000-09-14 |
| BR9908825A (pt) | 2000-11-21 |
| ID27596A (id) | 2001-04-12 |
| CA2323896A1 (en) | 1999-09-23 |
| CN1300286A (zh) | 2001-06-20 |
| PL342931A1 (en) | 2001-07-16 |
| AU2847199A (en) | 1999-10-11 |
| NO20004583L (no) | 2000-09-15 |
| IL138390A0 (en) | 2001-10-31 |
| JP2002506865A (ja) | 2002-03-05 |
| HUP0101215A3 (en) | 2002-05-28 |
| WO1999047519A1 (en) | 1999-09-23 |
| SK13622000A3 (sk) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| HU9503605D0 (en) | Use of nona- and decapeptides in the preparation of a drug for the treatment of aids | |
| PL327735A1 (en) | Novel substituted derivatives of imidazole | |
| MY114014A (en) | Imidazole compounds, compositions and use | |
| HK1022624A1 (en) | Novel substituted imidazole compounds. | |
| CY2473B1 (en) | New phenanthridines. | |
| PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
| MY136037A (en) | Biphenyl pyrimidone lp-pla2 inhibitors | |
| HK1029922A1 (en) | Angiostatic agents and compositions for treating glc1a glaucoma | |
| MY122391A (en) | Piperazine derivatives as 5-ht1b antagonists | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| MXPA04004503A (es) | Derivados de piperina y su uso como moduladores de actividad receptora de quimiocina (especialmente ccr5). | |
| SE9802208D0 (sv) | Novel compounds | |
| AU2838101A (en) | Use of melatonin for treating androgenetic and diffuse alopecia | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
| IL135825A0 (en) | Use of mirtazapine for treating sleep apneas | |
| IL150125A0 (en) | Novel compounds | |
| AU1191795A (en) | Deuterated active substances in transdermal application | |
| HK1029944A1 (en) | Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway | |
| TR200403001T3 (tr) | Lovastatin ve simvastatinin, azaltılmış dimerik katışkı seviyelerine sahip olacak şekilde arıtılması için bir işlem | |
| NO20006547L (no) | Salter av paroxetine | |
| AP2000001907A0 (en) | Crystalline form of paroxetine. | |
| SE9802209D0 (sv) | Novel compounds | |
| NZ515531A (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |